Research Site

Mettmann 40822

1 studies enrolling now · 5 studies all time

What they study most

Chronic Kidney Disease, High-risk Muscle Invasive Urothelial Carcinoma, Hormone-Sensitive Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Secondary Hyperparathyroidism

Studies at this site

• An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC — Recruiting now
• Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents — Running, not enrolling
• Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer — Running, not enrolling
• Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency — Running, not enrolling
• Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet — Completed